Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Varian Pharmed is an Iranian specialty pharmaceutical company focused on formulation innovation, especially long-acting injectables and extended-release medicines. The company markets a portfolio spanning reproductive health, oncology-supportive and endocrine therapies, pain and anesthesia, addiction treatment, and general hospital injectables. Its core differentiator is drug-delivery know-how in novel drug delivery systems, including in-situ forming PLGA-based depot formulations for peptides and small molecules. Varian Pharmed operates as part of Golrang Pharmaceutical Investment Co. and has built manufacturing and export capabilities serving Iran and selected international markets. The business appears to be primarily a commercial-stage branded generics and specialty formulations company rather than a clinical-stage biotech with a novel therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Varian Pharmed.